sci-hub.se 参考文章(12)
Romain A. Pauwels, GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION アレルギー. ,vol. 45, pp. 792- ,(1996)
Michael Noonan, Phillip Korenblat, Sofia Mosesova, Heleen Scheerens, Joseph R. Arron, Yanan Zheng, Wendy S. Putnam, Merdad V. Parsey, Sean P. Bohen, John G. Matthews, Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids The Journal of Allergy and Clinical Immunology. ,vol. 132, pp. 567- 574 ,(2013) , 10.1016/J.JACI.2013.03.051
Laura De Ferrari, Alessandra Chiappori, Diego Bagnasco, Anna Maria Riccio, Giovanni Passalacqua, Giorgio Walter Canonica, Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma? Expert Review of Respiratory Medicine. ,vol. 10, pp. 29- 38 ,(2016) , 10.1586/17476348.2016.1111763
Giovanni Passalacqua, Giorgio Walter Canonica, Allergen Immunotherapy: History and Future Developments Immunology and Allergy Clinics of North America. ,vol. 36, pp. 1- 12 ,(2016) , 10.1016/J.IAC.2015.08.001
Tuyet-Hang Pham, Gautam Damera, Paul Newbold, Koustubh Ranade, Reductions in eosinophil biomarkers by benralizumab in patients with asthma Respiratory Medicine. ,vol. 111, pp. 21- 29 ,(2016) , 10.1016/J.RMED.2016.01.003
Gilda Varricchi, Diego Bagnasco, Francesco Borriello, Enrico Heffler, Giorgio W Canonica, None, Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs Current Opinion in Allergy and Clinical Immunology. ,vol. 16, pp. 186- 200 ,(2016) , 10.1097/ACI.0000000000000251
Jeffrey R. Stokes, Thomas B. Casale, Characterization of asthma endotypes: implications for therapy Annals of Allergy Asthma & Immunology. ,vol. 117, pp. 121- 125 ,(2016) , 10.1016/J.ANAI.2016.05.016
J Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta, Marek Lommatzsch, Gary T Ferguson, William W Busse, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Viktoria Werkström, Magnus Aurivillius, Mitchell Goldman, Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial The Lancet. ,vol. 388, pp. 2128- 2141 ,(2016) , 10.1016/S0140-6736(16)31322-8
Eugene R Bleecker, J Mark FitzGerald, Pascal Chanez, Alberto Papi, Steven F Weinstein, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Magnus Aurivillius, Viktoria Werkström, Mitchell Goldman, Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial The Lancet. ,vol. 388, pp. 2115- 2127 ,(2016) , 10.1016/S0140-6736(16)31324-1
Giuseppe Santini, Nadia Mores, Mario Malerba, Chiara Mondino, Roberta Anzivino, Giuseppe Macis, Paolo Montuschi, Dupilumab for the treatment of asthma Expert Opinion on Investigational Drugs. ,vol. 26, pp. 357- 366 ,(2017) , 10.1080/13543784.2017.1282458